...
首页> 外文期刊>Trends in Ecology & Evolution >Development and ex-vivo skin permeation studies of finasteride-poly(lactic acid-co-glycolic acid) and minoxidil-chitosan nanoparticulate systems
【24h】

Development and ex-vivo skin permeation studies of finasteride-poly(lactic acid-co-glycolic acid) and minoxidil-chitosan nanoparticulate systems

机译:多甾醇 - 聚(乳酸 - 共乙醇酸)和明二氧化硅 - 壳聚糖纳米颗粒系统的开发和前体内皮肤渗透研究

获取原文
获取原文并翻译 | 示例

摘要

This study was designed to improve the permeability of two drugs (finasteride and minoxidil) through the skin. Finasteride-loaded poly(lactic acid-co-glycolic acid) and minoxidil-loaded chitosan nanoparticles were prepared by nanoprecipitation and ionic gelation method, respectively, and subsequently incorporated into semisolid Carbopol 940 gel. These fabricated nanoparticles were characterized for their pharmaceutical and chemical behavior. Nanoparticles were found a nearly spherical shape in the scanning electron microscopic studies and exhibited particle size in a range of 211-1012 nm. Finasteride- and minoxidil-loaded nanoparticles were optimized for relatively higher entrapment efficiency of 98% and 95%, respectively, by using the optimal concentration of polymers and stabilizers. All formulations were clear with smooth homogeneous texture and having pH values compatible with that of skin. This nanoparticulate system suspended in gel prolonged the release of drugs for up to 24 h and enhanced the drug permeability through the skin and retention of drug-loaded nanoparticles within the hair follicular routes. Therefore, these nanoparticles incorporated in the gel were found as a promising candidate for topical application in the treatment of alopecia by reducing the dosing frequency and adverse effects and as an effective strategy for improving the patient compliance toward therapy.
机译:本研究旨在通过皮肤提高两种药物(三甾胺和Minoxidil)的渗透性。通过纳米沉淀和离子凝胶化方法,分别制备了聚焦纤维化的聚(乳酸 - 共乙醇酸)和含氧化茄酰基壳聚糖纳米粒子,随后掺入半固体Carbopol 940凝胶中。这些制造的纳米颗粒的特征在于其药物和化学行为。在扫描电子显微镜研究中发现纳米颗粒是几乎球形的形状,并且在211-1012nm的范围内表现出粒度。通过使用聚合物和稳定剂的最佳浓度,分别优化了聚亚烷基和含有含有明酰胺和纳米氧化胺的纳米颗粒的98%和95%。所有制剂都是透明的,具有光滑的均匀质地,并具有与皮肤相容的pH值。该纳米颗粒系统悬浮在凝胶中,延长了24小时的药物释放,并通过皮肤增强了药物渗透性,并在毛毛线途径内保持药物纳米颗粒。因此,通过降低给药频率和不良反应,发现掺入凝胶中的这些纳米颗粒作为局部应用的局部申请,并作为改善患者对治疗患者依从性的有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号